Peer-reviewedCC BY 4.0Cell Reports
NAD+ precursor treatment prevents cardiomyopathy but disrupts erythroid maturation in mitochondrial progeria
Related
- CD98hc marks a precursor of human stem cell-derived alpha cells primed for functional maturation
- Autophagy Defects and Mitochondrial Retention in Erythroid Diseases
- Cost-effectiveness of infertility treatment pathways in PCOS: where does oocyte in-vitro maturation fit?
- Sotagliflozin corrects myocardial phenotype, mitochondrial gene expression and oxidative stress in mice with hypertrophic cardiomyopathy.
- Granulosa Cell Conditioned Medium Enhanced In Vitro Maturation and Developmental Potential of Mice Oocytes by Improving Mitochondrial Function, ATP Synthesis, and REDOX System
BibTeX
@article{khan2026precursor,
title = {{NAD+ precursor treatment prevents cardiomyopathy but disrupts erythroid maturation in mitochondrial progeria}},
author = {Nahid A. Khan and Kati Ahlqvist and Swagat Pradhan and Juan Landoni and Christopher Jackson and Aleksandra Zhaivoron and Riikka Kivelä and Liliya Euro and Anu Suomalainen},
journal = {Cell Reports},
year = {2026},
month = oct,
doi = {10.1016/j.celrep.2026.118179},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2211124726012581},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - NAD+ precursor treatment prevents cardiomyopathy but disrupts erythroid maturation in mitochondrial progeria
AU - Nahid A. Khan
AU - Kati Ahlqvist
AU - Swagat Pradhan
AU - Juan Landoni
AU - Christopher Jackson
AU - Aleksandra Zhaivoron
AU - Riikka Kivelä
AU - Liliya Euro
AU - Anu Suomalainen
PY - 2026
DA - 2026/10/01
JO - Cell Reports
DO - 10.1016/j.celrep.2026.118179
UR - https://linkinghub.elsevier.com/retrieve/pii/S2211124726012581
SN - 2211-1247
ER -